Literature DB >> 862280

Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.

H W Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862280

Source DB:  PubMed          Journal:  Clin Oncol        ISSN: 0305-7399


× No keyword cloud information.
  4 in total

1.  Treatment of benign breast disease with bromocriptine.

Authors:  A Mussa; L Dogliotti
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

Review 2.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Prognostic significance of serum prolactin levels in advanced breast cancer.

Authors:  M Dowsett; G E McGarrick; A L Harris; R C Coombes; I E Smith; S L Jeffcoate
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

4.  Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.

Authors:  A L Harris; M Dowsett; I E Smith; S Jeffcoate
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.